5.00 USD
↗ 0.00 (0.10%)PRE MARKET (AS OF 06:37 AM EDT)
LENZ Therapeutics, Inc. Common Stock
LENZNASDAQ • USD
Market: OPEN
Shares of LENZ Therapeutics, Inc. Common Stock (LENZ) are trading at $5.00. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place LENZ at a fair price relative to peers.
Technical & fundamental data as of Jul 15, 2026.
Open?$5.00
High?$5.06
Low?$4.99
Prev. Close?$4.99
Volume?2.0K
Avg. Volume?860.6K
VWAP?$5.01
Rel. Volume?0.00x
Bid / Ask
Bid?$4.27 × 100
Ask?$5.66 × 100
Spread?$1.39
Midpoint?$4.97
Valuation & Ratios
Market Cap?156.5M
Shares Out?31.4M
Float?18.3M
Float %?58.3%
P/E Ratio?N/A
P/B Ratio?0.63
EPS?-$3.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Employees
152
Market Cap
154.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-03-22
Address
201 LOMAS SANTA FE DRIVE, SUITE 300
SOLANA BEACH, CA 92075
Phone: 858-925-7000
SOLANA BEACH, CA 92075
Phone: 858-925-7000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?33
Momentum?18
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?1.94Grey
Confidence?58%Low
Short InterestSqueeze Risk
Short % of Float?57.12%Squeeze Risk
Short Interest?10.4M
Days to Cover?11.0
Free Float18.3M
Avg Daily Volume945.5K
Settlement Date2026-06-30
Financial Health
Current Ratio?10.40Strong
Quick Ratio?10.26Strong
Cash Ratio?0.96Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?0.63CHEAP▾
Peers100
S&P97
P/S?7.45HIGH▾
Peers100
S&P15
P/FCF?N/A▾
EV/EBITDA?-1.1CHEAP▾
S&P97
EV/Sales?6.27HIGH▾
Peers100
S&P26
Returns & Efficiency
ROE?-44.2%WEAK▾
S&P3
ROA?-40.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-87438000
Enterprise Value?$131.7M
Fundamentals ratios updated end of day